Report center

中药行业专题报告：从日本汉方药看中药行业高质量发展-20230519-国开证券

日本汉方药源于我国，在日本已经有1400多年的发展历史。汉方药市场规模相比我国较小，同时在日本药品市场的占比也低于我国，主要由于政策、监管、制度等制约因素及历史基础与我国有较大差异有关。汉方药市场对标国内刚起步的经典名方市场，行业监管规范、集中度高、发展周期长、以品质著称、同时也诞生了较为成功的企业-日本津村，或对我国现阶段中药行业高质量发展提供借鉴。日本津村2021年实现销售收入约1300亿

No subject companies

Publishers

国开证券 View content →

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

Ask about this report neighborhood Read full report →

Other hot industries

Healthcare Services View content →

No related reports

← Back to knowledge graph